Clinicopathological Characteristics | BC Patients | |
No. | % | |
Age | 52.23 ± 9.53 | |
Menopausal Status |
|
|
Pre-menopausal | 13 | 21.7% |
Post-menopausal | 47 | 78.3% |
Family History |
|
|
Negative | 51 | 85% |
Positive | 9 | 15% |
Type of Surgery |
|
|
Modified Radical Mastectomy | 60 | 100% |
Tumor Type |
|
|
Invasive Ductal Carcinoma | 60 | 100% |
Estrogen Receptor (ERα) Expression |
|
|
- | 7 | 11.7% |
+ | 20 | 33.3% |
++ | 25 | 41.7% |
+++ | 8 | 13.3% |
Progesterone Receptor (PR) Expression |
|
|
- | 10 | 16.7% |
+ | 24 | 40% |
++ | 20 | 33.3% |
+++ | 6 | 10% |
Her2/neu Expression |
|
|
- | 35 | 58.4% |
+ | 8 | 13.3% |
++ | 8 | 13.3% |
+++ | 5 | 8.3% |
Unknown | 4 | 6.7% |
Tumor size (Cm) |
|
|
T1 (≤2) | 17 | 28.3% |
T2 (2 - ≤5) | 37 | 61.7% |
T3 (>5) | 6 | 10% |
Lymph Nodes Involvement |
|
|
N0 | 14 | 23.3% |
N1 (1 - 3) | 25 | 41.7% |
N2 (4 - 9) | 3 | 5% |
N3 (>9) | 18 | 30% |